Crcle Guaifensin Extended Release Tablet, 1200 Mg Tablet
Product Images NDC 57483-280

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Crcle Guaifensin Extended Release Tablet, 1200 Mg (NDC 57483-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Innovus Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ggf 1200 Example)

Label for Circle Guaifenesin Extended-Release Tablets 1200 mg, an expectorant in tablet form by Innovus Pharmaceuticals. The label highlights 12-hour relief, chest congestion relief, and mucus thinning. It includes a drug facts panel with dosage, warnings, inactive ingredients, and a barcode. The package contains 56 extended-release bi-layer tablets.*

FDA Label Image

Image Description (Ggf 600 Carton)

The image shows the label for C'rcle Guaifenesin Extended-Release Tablets, 600 mg, an expectorant. The label states it provides relief for chest congestion, thins and loosens mucus, and offers immediate and extended release of the medication. The package contains 100 extended-release bi-layer tablets. The Drug Facts panel lists active ingredient, uses, warnings, directions, and inactive ingredients. The product is labeled for oral use and is manufactured by Innovus Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.